|
Andrew R. Muir joined the Corporation as a Director in December 2004. Dr. Muir is currently a private consultant advising emerging technology companies on a broad range of strategic and operational matters. Following his 20 year career with Perkin Elmer Corporation in the U.S. and Europe, where he had positions of increasing responsibility in Engineering and Operations Management, he has served in a variety of management and advisory roles with emerging technology companies. Most recently, he served as Chairman and Chief Executive Officer of Select Therapeutics, Inc., a development stage pharmaceutical company engaged in the development of novel pharmaceutical treatments utilizing technologies licensed from academic institutions. He continues to serve as a member of the Board of Directors of the company. Dr. Muir received his Doctoral Degree from Oxford University in the United Kingdom and MBA from Pace University in New York.
| 